Ballentine Partners’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
Ballentine Partners's STE Position: Q3 2026 in Review
Ballentine Partners increased its Steris (STE) stake by 5.7% in Q3 2026, buying an estimated $21.8K and bringing the position to 1,822 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #714.
Ballentine Partners first reported a position in STE in Q2 2024 and has held it in 9 quarters since. The position peaked at $506K in Q1 2026. 683 funds tracked by Wall St. Rank hold STE as of Q3 2026.
- Ballentine Partners held 1,822 shares of Steris worth $383K as of Q3 2026.
- Ballentine Partners bought 98 Steris shares in Q3 2026, an estimated $21.8K.
- Steris made up ﹤0.01% of Ballentine Partners's portfolio in Q3 2026, its #714 holding.
- Ballentine Partners first reported a position in Steris in Q2 2024 and has held it in 9 quarters since.
- Ballentine Partners's Steris position peaked at $506K in Q1 2026.
- 683 funds tracked by Wall St. Rank held Steris as of Q3 2026.
Based on Ballentine Partners's 13F filing for Q3 2026, filed 13 Nov 2026.